Dr. Mike Cusnir, MD
Claim this profileMount Sinai Medical Center
Studies Colorectal Cancer
Studies Adenocarcinoma
29 reported clinical trials
57 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
BRAF positive
RAS positive
2Adenocarcinoma
Stage IV
Stage III
dMMR negative
Affiliated Hospitals
Clinical Trials Mike Cusnir, MD is currently running
SHR-A1904
for Advanced Cancer
This trial is testing a new drug called SHR-A1904 to see if it is safe and effective for people with advanced solid tumors. The study will determine the best dose to use and check how the drug moves through the body. Researchers also want to know if the drug helps fight cancer without causing harmful side effects.
Recruiting1 award Phase 1 & 2
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Mike Cusnir, MD
Clinical Trial Related2 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Mike Cusnir, MD has experience with
- Oxaliplatin
- Fluorouracil
- Gemcitabine
- Placebo
- Docetaxel
- Ipilimumab
Breakdown of trials Mike Cusnir, MD has run
Colorectal Cancer
Adenocarcinoma
Prostate Cancer
Bile Duct Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mike Cusnir, MD specialize in?
Mike Cusnir, MD focuses on Colorectal Cancer and Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Mike Cusnir, MD currently recruiting for clinical trials?
Yes, Mike Cusnir, MD is currently recruiting for 12 clinical trials in Miami Beach Florida. If you're interested in participating, you should apply.
Are there any treatments that Mike Cusnir, MD has studied deeply?
Yes, Mike Cusnir, MD has studied treatments such as Oxaliplatin, Fluorouracil, Gemcitabine.
What is the best way to schedule an appointment with Mike Cusnir, MD?
Apply for one of the trials that Mike Cusnir, MD is conducting.
What is the office address of Mike Cusnir, MD?
The office of Mike Cusnir, MD is located at: Mount Sinai Medical Center, Miami Beach, Florida 33140 United States. This is the address for their practice at the Mount Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.